R. Volckmann

Affiliatie UvA

Specialization

Focus of research

Latest publications

Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancer
Villora, S. A., Zhao, Y., Silva, P. C., Hahn, A. A., Olanin, V., Groll, D., Maurer, S., Roetzer, V., Szymanski, W., Procida-Kowalski, T., Philipp, N., Koch, A., Bartkuhn, M., Graumann, J., Volckmann, R., Koster, J., Rossbach, O., Salzig, D., Dammann, R. & Sigges, C. & 3 others, Halbritter, J., Haerteis, S. & Richter, A. M., 1 Dec 2025, In: Clinical epigenetics. 17, 1, 102.
Research output: Contribution to journal › Article* › Academic › peer-review
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325, (S0959804922005172), (10.1016/j.ejca.2022.09.001)]
Langenberg, K. P. S., Meister, M. T., Bakhuizen, J. J., Boer, J. M., van Eijkelenburg, N. K. A., Hulleman, E., Ilan, U., Looze, E. J., Dierselhuis, M. P., Lugt, J. V. D., Breunis, W., Schild, L. G., Ober, K., van Hooff, S. R., Scheijde-Vermeulen, M. A., Hiemcke-Jiwa, L. S., Flucke, U. E., Kranendonk, M. E. G., Wesseling, P. & Sonneveld, E. & 34 others, Punt, S., Boltjes, A., van Dijk, F., Verwiel, E. T. P., Volckmann, R., Hehir-Kwa, J. Y., Kester, L. A., Koudijs, M. M. J., Waanders, E., Holstege, F. C. P., Vormoor, H. J., Hoving, E. W., Noesel, M. M. V., Pieters, R., Kool, M., Stumpf, M., Blattner-Johnson, M., Balasubramanian, G. P., van Tilburg, C. M., Jones, B. C., Jones, D. T. W., Witt, O., Pfister, S. M., Jongmans, M. C. J., Kuiper, R. P., de Krijger, R. R., Wijnen, M. H. W., den Boer, M. L., Zwaan, C. M., Kemmeren, P., Koster, J., Tops, B. B. J., Goemans, B. F. & Molenaar, J. J., 15 May 2025, In: Eur. J. Cancer. 221, 115423.
Research output: Contribution to journal › Comment/Letter to the editor* › Academic
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy
Huijbers, E. J. M., van Beijnum, J. R., van Loon, K., Griffioen, C. J., Volckmann, R., Bassez, A., Lambrechts, D., Monteiro, M. N., Jimenez, C. R., Hogendoorn, P. C. W., Koster, J. & Griffioen, A. W., 25 Mar 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 12, e2424730122.
Research output: Contribution to journal › Article* › Academic › peer-review
All publications

R. Volckmann

Specialization

Focus of research

Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancer

Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325, (S0959804922005172), (10.1016/j.ejca.2022.09.001)]

Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy

Amsterdam UMC makes use of cookies